Related Experiment Video
Updated: Feb 13, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
Published on: June 9, 2023
RET mutation heterogeneity in primary advanced medullary thyroid cancers and their metastases
Cristina Romei1, Raffaele Ciampi1, Francesca Casella1
1Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy.
Purpose:
Medullary Thyroid Cancer (MTC) whose pathogenesis is strictly related to RET proto-oncogene alterations, has been shown to have a heterogenic RET mutation profile in subpopulations of MTC. The aim of our study was to investigate the RET somatic mutation profile in primary MTC and in the corresponding metastatic tissues in a series of advanced metastatic cases.
Results:
This study demonstrated that in about 20% of cases a different RET mutation profile can be found when comparing primary tumor and its corresponding metastases. Furthermore in 8% of tumors, RET intratumor heterogeneity was observed We also showed that in some cases an imbalance of RET copy number was present. We confirmed a high prevalence (90%) of RET somatic mutations in advanced tumors.
Materials And Methods:
Fifty-six MTC patients (50 somatic and 6 hereditary cases) have been included in the study and a total of 209 specimens have been analysed by direct sequencing. Multiplex ligation-dependent probe amplification (MLPA) has been used to investigate amplification/deletion of RET alleles.
Conclusions:
In conclusion, this study showed a genetic intra- and intertumor heterogeneity in MTC, But in only 20% of CASES These results could justify the relatively moderate level of aggressiveness of the disease with respect to more aggressive human tumors that are characterized by a high rate of mutation and heterogeneity.
Insights
Medullary thyroid cancer (MTC) shows genetic heterogeneity in RET mutations between primary and metastatic tumors. This RET genetic variation was observed in approximately 20% of advanced MTC cases studied.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Medullary Thyroid Cancer (MTC) pathogenesis is linked to RET proto-oncogene alterations.
- Previous studies indicate a heterogeneous RET mutation profile within MTC subpopulations.
Purpose of the Study:
- To investigate the RET somatic mutation profile in primary MTC and corresponding metastatic tissues.
- To analyze advanced metastatic MTC cases for RET genetic heterogeneity.
Main Methods:
- Analysis of 209 specimens from 56 MTC patients (50 somatic, 6 hereditary).
- Direct sequencing used to determine RET mutation profiles.
- Multiplex ligation-dependent probe amplification (MLPA) assessed RET allele copy number variations.
Main Results:
- A distinct RET mutation profile was observed in primary versus metastatic tissues in ~20% of cases.
- Intratumor RET heterogeneity was detected in 8% of MTC tumors.
- RET somatic mutations were highly prevalent (90%) in advanced MTC.
- Imbalances in RET copy number were identified in some patients.
Conclusions:
- This study confirms significant genetic intra- and intertumor heterogeneity in MTC.
- The observed heterogeneity, while present, is less pronounced than in highly aggressive human tumors.
- Findings may help explain the moderate aggressiveness of MTC compared to other cancers.
Related Concept Videos
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancers Originate from Somatic Mutations in a Single Cell
Viral Mutations
The Thyroid Gland
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
Mutation, Gene Flow, and Genetic Drift

